FDA clears Lilly's Gemzar as treatment for certain cancer
Submitted by ipsita on Sat, 1997-12-27 10:30
The Food and Drug Administration gave approval to Eli Lilly and Co.'s Gemzer anticancer compound for first-line therapy against non-small-cell lung cancer, a potentially significantly development for
Main Topic:
Mark Content Private(Internal):
Clipping Type:
DNB
External URL:
Main Type:
dte-DNB
Publication Date:
27/12/1997